NDC 71403-049

Sitavig

Acyclovir

Sitavig is a Buccal Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Epi Health, Inc. The primary component is Acyclovir.

Product ID71403-049_2a940f29-623c-4c7f-8630-1a157c13543e
NDC71403-049
Product TypeHuman Prescription Drug
Proprietary NameSitavig
Generic NameAcyclovir
Dosage FormTablet, Delayed Release
Route of AdministrationBUCCAL
Marketing Start Date2014-03-20
Marketing CategoryNDA / NDA
Application NumberNDA203791
Labeler NameEPI Health, Inc
Substance NameACYCLOVIR
Active Ingredient Strength50 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71403-049-02

1 BLISTER PACK in 1 CARTON (71403-049-02) > 2 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Marketing Start Date2014-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71403-049-01 [71403004901]

Sitavig TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA203791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-03-20
Marketing End Date2019-06-06

NDC 71403-049-02 [71403004902]

Sitavig TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA203791
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-03-20

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR50 mg/1

OpenFDA Data

SPL SET ID:cd6e902d-5753-49ec-bec8-b27176ed978e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1423662
  • 1493276
  • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "Sitavig" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    68712-049SitavigSitavig
    71403-049SitavigSitavig
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    0187-0993Zoviraxacyclovir
    0187-0994Zoviraxacyclovir
    0378-9735ZoviraxAcyclovir

    Trademark Results [Sitavig]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SITAVIG
    SITAVIG
    85247490 4044319 Live/Registered
    VECTANS PHARMA
    2011-02-21

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.